
The pharmaceutical sector stands on the precipice of significant growth, driven by a rapidly burgeoning market for medications and vaccines. Additionally, this sector's sustained product demands underscore its resilience, making it less susceptible to economic volatility.
Given this backdrop, fundamentally strong pharma stocks Organon & Co. (OGN), GoodRx Holdings, Inc. (GDRX), and Viatris Inc. (VTRS), trading under $15, could be worth your attention.